News
Sygnature Creates Second Integrated Drug Discovery Site at Alderley Park
Sygnature Discovery has begun expanding into new state of the art laboratories at Alderley Park, Cheshire, adding Chemistry and Biology expertise to its DMPK and Translational Oncology teams already present on the site.
Creating truly integrated interdisciplinary teams, co-located in...
News
AMRI Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine
Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.
For the...
News
Calyx Offers Scientific Consulting to Optimize Clinical Development
Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of...
News
Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing...
News
Merck to Manufacture Next-Generation Biotherapeutics for Alteogen
Merck, a leading science and technology company, announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through Merck’s BioReliance® End-to-End Solutions. Alteogen selected Merck to develop and produce recombinant biologics for the development and clinical...
News
UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development
UCB and Microsoft have announced a new multi-year, strategic collaboration to combine Microsoft’s computational services, cloud, and artificial intelligence (AI) with UCB’s drug discovery and development capabilities. As several drug discovery activities require the analysis of high-dimensional data sets...
News
Egyptian Drug Authority approves Sputnik V vaccine for emergency use
The Egyptian Drug Authority has approved the Russian Direct Investment Fund’s (RDIF) Covid-19 vaccine, Sputnik V, under the emergency use authorisation (EUA) procedure.
The Egyptian Drug Authority has approved the Russian Direct Investment Fund’s (RDIF) Covid-19 vaccine, Sputnik V, under...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















